摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[4-氨基-2-(甲基氨基)-1,3-噻唑-5-基](苯基)甲酮 | 107401-74-1

中文名称
[4-氨基-2-(甲基氨基)-1,3-噻唑-5-基](苯基)甲酮
中文别名
——
英文名称
(4-Amino-2-methylamino-thiazol-5-yl)-phenyl-methanone
英文别名
[4-Amino-2-(methylamino)-1,3-thiazol-5-yl](phenyl)methanone;[4-amino-2-(methylamino)-1,3-thiazol-5-yl]-phenylmethanone
[4-氨基-2-(甲基氨基)-1,3-噻唑-5-基](苯基)甲酮化学式
CAS
107401-74-1
化学式
C11H11N3OS
mdl
MFCD04060946
分子量
233.294
InChiKey
SQWPGESDJHLLBD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    195 °C
  • 沸点:
    454.7±55.0 °C(Predicted)
  • 密度:
    1.356±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    96.2
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Studies on the Synthesis of 5-Acyl-2,4-diaminothiazoles from Amidinothioureas
    摘要:
    1-烷基或芳基-3-脒基硫脲与δ-卤酮反应或不反应,生成 5-酰基-2,4-二氨基噻唑。
    DOI:
    10.1055/s-1986-31634
点击查看最新优质反应信息

文献信息

  • Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
    作者:Ernst Schonbrunn、Stephane Betzi、Riazul Alam、Mathew P. Martin、Andreas Becker、Huijong Han、Rawle Francis、Ramappa Chakrasali、Sudhakar Jakkaraj、Aslamuzzaman Kazi、Said M. Sebti、Christopher L. Cubitt、Anthony W. Gebhard、Lori A. Hazlehurst、Joseph S. Tash、Gunda I. Georg
    DOI:10.1021/jm301234k
    日期:2013.5.23
    Cyclin-dependent kinases (CDKs) are serine/threonine protein kinases that act as key regulatory elements in cell cycle progression. We describe the development of highly potent diaminothiazole inhibitors of CDK2 (IC50 = 0.0009-0.0015 mu M) from a single hit compound with weak inhibitory activity (IC50 = 15 mu M), discovered by high-throughput screening. Structure-based design was performed using 35 cocrystal structures of CDK2 liganded with distinct analogues of the parent compound. The profiling of compound 51 against a panel of 339 kinases revealed high selectivity for CDKs, with preference for CDK2 and CDK5 over CDK9, CDK1, CDK4, and CDK6. Compound 51 inhibited the proliferation of 13 out of 15 cancer cell lines with IC50 values between 0.27 and 6.9 mu M, which correlated with the complete suppression of retinoblastoma phosphorylation and the onset of apoptosis. Combined, the results demonstrate the potential of this new inhibitors series for further development into CDK-specific chemical probes or therapeutics.
  • RAJASEKHARAN, K. N.;NAIR, K. P.;JENARDANAN, G. C., SYNTHESIS, BRD, 1986, N 5, 353-355
    作者:RAJASEKHARAN, K. N.、NAIR, K. P.、JENARDANAN, G. C.
    DOI:——
    日期:——
查看更多